UBLITUXIMAB

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Approval Year

Substance Class	Protein Created by `admin` on `Fri Dec 15 20:01:23 GMT 2023` Edited by `admin` on `Fri Dec 15 20:01:23 GMT 2023`
Protein Type	MONOCLONAL ANTIBODY
Protein Sub Type	IGG1
Sequence Origin	MOUSE CHIMERIC
Sequence Type	COMPLETE
Record UNII	U59UGK3IPC
Record Status	`Validated (UNII)`
Record Version

Download

Related Record	Type

Name

Type

Language

UBLITUXIMAB

Official Name

English

R603

Code

English

TG-1101

Code

English

LFB-R 603

Code

English

EMAB6

Code

English

TGT-1101

Code

English

UBLITUXIMAB [USAN]

Common Name

English

LFBR603

Code

English

ublituximab [INN]

Common Name

English

TGT1101

Code

English

EMAB-6

Code

English

R-603

Code

English

IMMUNOGLOBULIN G1, ANTI-(HUMAN CD20 (ANTIGEN)) (HUMAN-MOUSE MONOCLONAL .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL .KAPPA.-CHAIN, DIMER

Common Name

English

TGTX1101

Code

English

TG1101

Code

English

Ublituximab [WHO-DD]

Common Name

English

TGTX-1101

Code

English

LFBR-603

Code

English

Classification Tree Code System Code

FDA ORPHAN DRUG

296609

Created by admin on Fri Dec 15 20:01:23 GMT 2023 , Edited by admin on Fri Dec 15 20:01:23 GMT 2023

NCI_THESAURUS

C20401

Created by admin on Fri Dec 15 20:01:23 GMT 2023 , Edited by admin on Fri Dec 15 20:01:23 GMT 2023

FDA ORPHAN DRUG

554216

Created by admin on Fri Dec 15 20:01:23 GMT 2023 , Edited by admin on Fri Dec 15 20:01:23 GMT 2023

FDA ORPHAN DRUG

533116

Created by admin on Fri Dec 15 20:01:23 GMT 2023 , Edited by admin on Fri Dec 15 20:01:23 GMT 2023

FDA ORPHAN DRUG

552216

Created by admin on Fri Dec 15 20:01:23 GMT 2023 , Edited by admin on Fri Dec 15 20:01:23 GMT 2023

FDA ORPHAN DRUG

403813

Created by admin on Fri Dec 15 20:01:23 GMT 2023 , Edited by admin on Fri Dec 15 20:01:23 GMT 2023

FDA ORPHAN DRUG

410913

Created by admin on Fri Dec 15 20:01:23 GMT 2023 , Edited by admin on Fri Dec 15 20:01:23 GMT 2023

Code System Code Type Description

DRUG BANK

DB11850

Created by admin on Fri Dec 15 20:01:23 GMT 2023 , Edited by admin on Fri Dec 15 20:01:23 GMT 2023

PRIMARY

FDA UNII

U59UGK3IPC

Created by admin on Fri Dec 15 20:01:23 GMT 2023 , Edited by admin on Fri Dec 15 20:01:23 GMT 2023

PRIMARY

INN

9334

Created by admin on Fri Dec 15 20:01:23 GMT 2023 , Edited by admin on Fri Dec 15 20:01:23 GMT 2023

PRIMARY

WIKIPEDIA

Ublituximab

Created by admin on Fri Dec 15 20:01:23 GMT 2023 , Edited by admin on Fri Dec 15 20:01:23 GMT 2023

PRIMARY

CAS

1174014-05-1

Created by admin on Fri Dec 15 20:01:23 GMT 2023 , Edited by admin on Fri Dec 15 20:01:23 GMT 2023

PRIMARY

NCI_THESAURUS

C91078

Created by admin on Fri Dec 15 20:01:23 GMT 2023 , Edited by admin on Fri Dec 15 20:01:23 GMT 2023

PRIMARY

USAN

CD-90

Created by admin on Fri Dec 15 20:01:23 GMT 2023 , Edited by admin on Fri Dec 15 20:01:23 GMT 2023

PRIMARY

EVMPD

SUB182428

Created by admin on Fri Dec 15 20:01:23 GMT 2023 , Edited by admin on Fri Dec 15 20:01:23 GMT 2023

PRIMARY

ChEMBL

CHEMBL2108354

Created by admin on Fri Dec 15 20:01:23 GMT 2023 , Edited by admin on Fri Dec 15 20:01:23 GMT 2023

PRIMARY

DAILYMED

U59UGK3IPC

Created by admin on Fri Dec 15 20:01:23 GMT 2023 , Edited by admin on Fri Dec 15 20:01:23 GMT 2023

PRIMARY

From	To
1_22	1_96
1_145	1_201
1_262	1_322
1_368	1_426
2_22	2_96
2_145	2_201
2_262	2_322
2_368	2_426
3_23	3_87
3_133	3_193
4_23	4_87
4_133	4_193
1_221	3_213
2_221	4_213
1_227	2_227
1_230	2_230

Glycosylation Type

MAMMALIAN, AFUCOSYLATED

Glycosylation Link Type	Site
N	1_298
N	2_298

Related Record Type Details

Ublituximab-XIIY

SUB_CONCEPT->SUBSTANCE

Amount:


					TB2Q79LBS0

B-LYMPHOCYTE ANTIGEN CD20

TARGET->LIGAND

Amount:

Related Record Type Details


					U59UGK3IPC

ACTIVE MOIETY

Amount:

Name	Property Type	Amount	Referenced Substance	Defining	Parameters	References
MOL_WEIGHT:NUMBER(CALCULATED)	CHEMICAL
Molecular Formula	CHEMICAL